Liver carcinoma
|
0.320 |
Biomarker
|
disease |
BEFREE |
The aim of the present study was to determine the effects of ARHI (aplasia Ras homologue member I; also known as DIRAS3), a member of the Ras superfamily, on HCC (hepatocellular carcinoma) cells and to define the molecular pathways involved.
|
21933150 |
2011 |
Liver carcinoma
|
0.320 |
AlteredExpression
|
disease |
BEFREE |
Our current observations provide evidences that ARHI downregulated in HCCs could play a role in liver cancer via acting as a tumor suppressor gene, which mainly was triggered by the epigenetic events in HCC specimens.
|
18612997 |
2009 |
Malignant Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
We found over-expression of ARHI can also inhibit cancer cell proliferation, decrease tumorigenicity, and induce autophagic cell death in human glioma and inhibition of the late stage of autophagy can further enhance the antitumor effect of ARHI through inducing apoptosis in vitro or vivo.
|
31088402 |
2019 |
Malignant Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
DIRAS3 is an imprinted tumor suppressor gene that encodes a 26 kD GTPase with homology to RAS that inhibits cancer cell proliferation and motility.
|
31003488 |
2019 |
Malignant Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Re-expression of the imprinted tumor suppressor gene DIRAS family GTPase 3 (DIRAS3) (aplysia ras homology member I [ARHI]) induces autophagy and tumor dormancy in ovarian cancer xenografts, but drives autophagic cancer cell death in cell culture.
|
30620384 |
2019 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
DIRAS3 is an imprinted tumor suppressor gene that encodes a 26 kD GTPase with homology to RAS that inhibits cancer cell proliferation and motility.
|
31003488 |
2019 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
DIRAS3 is a tumor suppressor gene downregulated in >60% of primary ovarian cancers by genetic, epigenetic, transcriptional and post-transcriptional mechanisms, that upon re-expression can induce autophagy and dormancy in a xenograft model of ovarian cancer.
|
31052266 |
2019 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
ARHI is a remarkable tumor suppressor gene in human ovarian cancer and many other cancers.
|
31088402 |
2019 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
DIRAS3 is a maternally imprinted tumor suppressor gene, located on chromosome 1p31, and implicated in growth and oncogenesis.
|
30916492 |
2019 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Re-expression of the imprinted tumor suppressor gene DIRAS family GTPase 3 (DIRAS3) (aplysia ras homology member I [ARHI]) induces autophagy and tumor dormancy in ovarian cancer xenografts, but drives autophagic cancer cell death in cell culture.
|
30620384 |
2019 |
Malignant neoplasm of ovary
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
The addition of VEGF, IGF-1, and IL-8 weakened the inhibitory effect of DIRAS3 on ERK/AKT activity and reduced DIRAS3-mediated TFEB or FOXo3a nuclear localization and MAPLC3B expression in ovarian cancer cells.
|
30620384 |
2019 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Previously reports showed that DIRAS3 inhibits cell proliferation and induces autophagy in ovarian, breast, lung and prostate cancers, which is heterozygosity loss or down-regulated in aforementioned cancers and functionally as a tumor suppressor, whereas the role of DIRAS3 in glioma is still veiled.
|
30266404 |
2018 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
DIRAS3 is downregulated in many tumor types, including ovarian cancer, where re-expression inhibits cancer cell growth, reduces motility, promotes tumor dormancy and induces macroautophagy/autophagy.
|
29368982 |
2018 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
Overexpression of DIRAS3 in BGC-823 cells elevated autophagy levels in subcutaneous xenograft and inhibited tumor growth in mice; the hematogenous liver and lung metastasis of cancer cells were also suppressed.
|
30043279 |
2018 |
Malignant neoplasm of ovary
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
DIRAS3 is downregulated in many tumor types, including ovarian cancer, where re-expression inhibits cancer cell growth, reduces motility, promotes tumor dormancy and induces macroautophagy/autophagy.
|
29368982 |
2018 |
Neoplasms
|
0.100 |
PosttranslationalModification
|
group |
BEFREE |
We therefore reasoned that ARHI is a novel epigenetic silenced tumor suppressor gene on chromosome 1p that is involved in sporadic PCC tumorigenesis.
|
29156798 |
2017 |
Malignant Neoplasms
|
0.100 |
PosttranslationalModification
|
group |
BEFREE |
ARHI is an imprinted tumor suppressor gene and its methylation suppresses ARHI transcription levels to cause the development and progression of malignant tumors.
|
27685841 |
2016 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
ARHI is an imprinted tumor suppressor gene and its methylation suppresses ARHI transcription levels to cause the development and progression of malignant tumors.
|
27685841 |
2016 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
ARHI (DIRAS3), an imprinted tumor suppressor gene, is downregulated in 60% of ovarian cancers.
|
26247722 |
2015 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
ARHI, an imprinted tumor-suppressor gene, is markedly down-regulated or even undetectable in the majority of EOC.
|
25077680 |
2015 |
Malignant neoplasm of ovary
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
ARHI (DIRAS3), an imprinted tumor suppressor gene, is downregulated in 60% of ovarian cancers.
|
26247722 |
2015 |
Malignant neoplasm of breast
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Overexpression of Sp1 inhibited breast cancer cell migratory and invasive abilities, whereas knockdown of GTP-binding RAS-like 3 (DIRAS3, also known as ARHI, NOEY2) attenuated the inhibitory effects.
|
25193278 |
2014 |
Malignant neoplasm of breast
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Breast cancer cells are arrested at different phases of the cell cycle following the re-expression of ARHI.
|
24676336 |
2014 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
Functional inhibition of autophagy with choroquine in dormant xenografts that express DIRAS3 significantly delays tumor regrowth after DIRAS3 levels are reduced, suggesting that autophagy sustains dormant ovarian cancer cells.
|
24879154 |
2014 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Taken together, these results suggest that ARHI acts as a tumor suppressor gene in MDA-MB-231 cells and, although TSA+DAC can block the cells at different cell cycle phage, the antitumor effect is ARHI-dependent.
|
24676336 |
2014 |